EU Slaps US Pharma: Pay Tariffs Or Swallow Pills Harder
In a masterstroke of diplomatic irony, the European Union’s new trade deal might cost US pharmaceuticals between $13 and $19 billion as their "branded medicines become subject to a tariff of 15%," analysts grimly noted on Monday. Despite exporting the largest share of medicines to America—about 60% of all pharma imports—Europe’s latest move feels like charging admission before giving the aspirin. As the article put it, "Medicines are the largest European exports to the U.S. by value," which is rich, considering the US now pays extra just to get these pricey pills past customs.
Share the Story
(1 of 3)Nothing says 'friendship' like the EU charging the US a 15% tariff on their own cold medicine. Sounds like a prescription for a trade war — and maybe heartburn.
Congrats to the EU turning already sky-high US drug prices into a luxury tax. Americans can afford insulin but can’t afford to skip the bill? That’s capitalism chewing on a bandage.
The EU slapped a 15% tariff on US pharma like it's the cover charge at a nightclub — except the party is just a cold coming on.
Source: Feeds | Published: 7/28/2025 | Author: Reuters
More Articles in Business
Motorola Razr Flip Phones Finally Told They’re Secure Enough for 2027
America Tries Staying Cool While Secretly Preparing For Wattocalypse
Canada Declares 'No American Goods' After US Says '50% More Please'
US and Canada Start Tariff Edition of Chips Ahoy Costume Party
Zillow Pays Redfin to Not Compete, Then Both Pupils Graduate Antitrust Class
KPMG’s Consulting Business Dies Dramatically While Staff Take a Hike
Man Applies to 200 Jobs with AI's Help, Still Does Own Eyerolling
